DK1765370T3 - Parapox-vira i kombination med andre antivirale midler til behandling af HIV/AIDS - Google Patents
Parapox-vira i kombination med andre antivirale midler til behandling af HIV/AIDSInfo
- Publication number
- DK1765370T3 DK1765370T3 DK05764629T DK05764629T DK1765370T3 DK 1765370 T3 DK1765370 T3 DK 1765370T3 DK 05764629 T DK05764629 T DK 05764629T DK 05764629 T DK05764629 T DK 05764629T DK 1765370 T3 DK1765370 T3 DK 1765370T3
- Authority
- DK
- Denmark
- Prior art keywords
- combination
- aids
- treatment
- antiviral agents
- hiv
- Prior art date
Links
- 241000700639 Parapoxvirus Species 0.000 title abstract 4
- 208000030507 AIDS Diseases 0.000 title abstract 2
- 239000003443 antiviral agent Substances 0.000 title abstract 2
- 238000011225 antiretroviral therapy Methods 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04016414 | 2004-07-13 | ||
| PCT/EP2005/007395 WO2006005529A1 (en) | 2004-07-13 | 2005-07-08 | Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1765370T3 true DK1765370T3 (da) | 2009-11-02 |
Family
ID=35115792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05764629T DK1765370T3 (da) | 2004-07-13 | 2005-07-08 | Parapox-vira i kombination med andre antivirale midler til behandling af HIV/AIDS |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8343478B2 (da) |
| EP (1) | EP1765370B1 (da) |
| JP (1) | JP4897677B2 (da) |
| CN (2) | CN103800382A (da) |
| AT (1) | ATE442155T1 (da) |
| BR (1) | BRPI0513321B1 (da) |
| CA (1) | CA2573204C (da) |
| DE (1) | DE602005016552D1 (da) |
| DK (1) | DK1765370T3 (da) |
| ES (1) | ES2330540T3 (da) |
| HK (1) | HK1097467A1 (da) |
| PL (1) | PL1765370T3 (da) |
| PT (1) | PT1765370E (da) |
| WO (1) | WO2006005529A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2873881A1 (en) * | 2012-05-18 | 2013-11-21 | Stephen Bruce Fleming | Combination treatments and compositions for wound healing |
| TW201919675A (zh) * | 2017-09-07 | 2019-06-01 | 德商艾庫瑞斯公司 | 使用羊副痘疹病毒(Parapoxvirus ovis；PPVO)及至少一種額外抗病毒藥之經B型肝炎病毒(HBV)感染之個體之組合療法 |
| WO2019170820A1 (en) | 2018-03-07 | 2019-09-12 | Transgene | Parapoxvirus vectors |
| LT3906970T (lt) * | 2020-05-08 | 2022-10-10 | Aicuris Gmbh & Co. Kg | Parapoxvirus, skirtas adaptacijai prie koronaviruso infekcijos ir gydymui |
| WO2023083943A1 (en) * | 2021-11-10 | 2023-05-19 | Aicuris Gmbh & Co. Kg | Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with antivirals |
| WO2023083950A1 (en) * | 2021-11-10 | 2023-05-19 | Aicuris Gmbh & Co. Kg | Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with immunomodulators |
| WO2024062098A1 (en) | 2022-09-23 | 2024-03-28 | Transgene | Recombinant pseudocowpox virus encoding an interleukin-12 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4405841C1 (de) * | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO1997032029A1 (de) * | 1996-02-28 | 1997-09-04 | Bayer Aktiengesellschaft | Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen |
| DE59704194D1 (de) * | 1996-04-15 | 2001-09-06 | Anton Mayr | Verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren zur herstellung von arzneimitteln |
| DE19922407A1 (de) * | 1999-05-14 | 2000-11-16 | Bayer Ag | Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus |
| PL366397A1 (en) * | 2000-07-11 | 2005-01-24 | Bayer Aktiengesellschaft | Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
-
2005
- 2005-07-08 EP EP05764629A patent/EP1765370B1/en active Active
- 2005-07-08 DE DE602005016552T patent/DE602005016552D1/de active Active
- 2005-07-08 JP JP2007520721A patent/JP4897677B2/ja not_active Expired - Fee Related
- 2005-07-08 DK DK05764629T patent/DK1765370T3/da active
- 2005-07-08 BR BRPI0513321-1A patent/BRPI0513321B1/pt not_active IP Right Cessation
- 2005-07-08 WO PCT/EP2005/007395 patent/WO2006005529A1/en not_active Application Discontinuation
- 2005-07-08 ES ES05764629T patent/ES2330540T3/es active Active
- 2005-07-08 CN CN201410015941.2A patent/CN103800382A/zh active Pending
- 2005-07-08 CN CNA2005800236070A patent/CN1984666A/zh active Pending
- 2005-07-08 PL PL05764629T patent/PL1765370T3/pl unknown
- 2005-07-08 CA CA2573204A patent/CA2573204C/en active Active
- 2005-07-08 PT PT05764629T patent/PT1765370E/pt unknown
- 2005-07-08 AT AT05764629T patent/ATE442155T1/de active
-
2007
- 2007-01-11 US US11/652,937 patent/US8343478B2/en active Active
- 2007-05-14 HK HK07105043.9A patent/HK1097467A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1765370B1 (en) | 2009-09-09 |
| EP1765370A1 (en) | 2007-03-28 |
| BRPI0513321A (pt) | 2008-05-06 |
| ATE442155T1 (de) | 2009-09-15 |
| PL1765370T3 (pl) | 2010-02-26 |
| US20100255032A1 (en) | 2010-10-07 |
| BRPI0513321B1 (pt) | 2022-03-08 |
| WO2006005529A1 (en) | 2006-01-19 |
| CA2573204C (en) | 2011-09-20 |
| CN103800382A (zh) | 2014-05-21 |
| PT1765370E (pt) | 2009-09-23 |
| US8343478B2 (en) | 2013-01-01 |
| JP4897677B2 (ja) | 2012-03-14 |
| CA2573204A1 (en) | 2006-01-19 |
| HK1097467A1 (en) | 2007-06-29 |
| ES2330540T3 (es) | 2009-12-11 |
| JP2008505952A (ja) | 2008-02-28 |
| DE602005016552D1 (de) | 2009-10-22 |
| CN1984666A (zh) | 2007-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200700243A1 (ru) | Способы лечения гепатита с | |
| DK1765370T3 (da) | Parapox-vira i kombination med andre antivirale midler til behandling af HIV/AIDS | |
| DE602006015861D1 (de) | Antivirale verbindungen | |
| FR16C0028I2 (fr) | Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques | |
| DE60216151D1 (de) | Langwirkende Fusionspeptidinhibitoren gegen HIV-Infektion | |
| EA200602289A1 (ru) | Применение иматиниба для лечения нарушений работы печени и вирусных инфекций | |
| EA201290993A1 (ru) | Нуклеозидфосфорамидаты | |
| HK1122291A1 (en) | Anti-viral compounds | |
| DK1747023T3 (da) | Fremgangsmåder og sammensætninger til formindskelse af HCV-virusgenommængder i en målcelle | |
| MX2010008148A (es) | Métodos de tratamiento de infecciones virales. | |
| AR057623A1 (es) | Materiales y metodos para el tratamiento de las infecciones virales | |
| MY144616A (en) | Substituted dihydroquinazolines | |
| NO20034878D0 (no) | Antivirale forbindelser | |
| MX2022016405A (es) | Análogos de nucleósido de 1¿-ciano y usos de estos. | |
| SG170825A1 (en) | Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production | |
| DOP2003000641A (es) | Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan | |
| GEP20237518B (en) | Combination therapies of hepatitis b virus (hbv)-infected individuals using parapoxvirus ovis (ppvo) and at least one further antiviral drug | |
| EA201170484A1 (ru) | Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950 | |
| WO2006043153A3 (en) | Use of zinc and copper chelators for the treatment of viral diseases | |
| EA201290852A1 (ru) | Комбинированная терапия, включающая антагонист ccr5, ингибитор протеазы вич-1 и фармакокинетический усилитель | |
| WO2004052905A3 (en) | Antiviral nucleoside derivatives | |
| DE602006016416D1 (de) | Verfahren zur anwendung von ionisierungsstrahlung bei einer hiv-infektionstherapie | |
| ATE521640T1 (de) | Anti-tsg101-antikörper und ihre verwendungen bei der behandlung von virusinfektionen | |
| TW200621800A (en) | Human immunodeficiency virus vaccine | |
| EA202092732A1 (ru) | АНТИТЕЛА, КОТОРЫЕ НАЦЕЛЕНЫ НА ГЛИКОПРОТЕИН gp120 ВИРУСА ИММУНОДЕФИЦИТА ЧЕЛОВЕКА (ВИЧ), И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |